• A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale
• A Novel Presentation of Refractory Immune Thrombocytopenia in Anti-synthetase Syndrome: A Case Report
• Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-κB pathways in experimental autoimmune myositis mice
• An epidemiological investigation of an idiopathic myopathy in hunting dogs in New Zealand
• Anti-Ro52/Anti-nuclear Matrix Protein 2 Positive Clinically Amyopathic Dermatomyositis Presented Only With Interstitial Lung Disease
• Association between self-reported race and ethnicity and myositis-specific autoantibodies in a diverse cohort of patients with inflammatory myopathy
• Can vitamin D be an adjuvant therapy for juvenile rheumatic diseases?
• Classical Dermatomyositis: A Case Report
• Correlation analysis of quantitative MRI measurements of thigh muscles with histopathology in patients with idiopathic inflammatory myopathy
• COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Disease
• Dermatomyositis
• Dermatomyositis post vaccine against SARS-COV2
• Displaced Myonuclei in Cancer Cachexia Suggest Altered Innervation
• Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
• First study demonstrating speckle tracking echocardiography has prognostic value in patients with idiopathic inflammatory myopathies
• High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies
• IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies
• Immunoglobulins in systemic sclerosis management. A large multicenter experience
• Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies
• Increased serum levels of sCD40L were associated with rapidly progressive interstitial lung disease in idiopathic inflammatory myopathies
• Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
• Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis
• Lung involvement in juvenile idiopathic inflammatory myopathy: A systematic review
• MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives
• Myopathy in a 61-year-old Hispanic man
• Patient-Reported Health-Related Quality of Life, Anxiety and Depression in Patients with Inclusion Body Myositis: A Register-Based Cross-Sectional Study in Germany
• Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity
• Polymyositis following varicella and mumps infection in adults: report of two cases
• Pyomyositis Secondary to Localized Cellulitis in a Dermatomyositis Patient: A Case Report and Review of Infectious Complications in Dermatomyositis
• Retinal microvascular abnormalities, cotton wool-like lesions, and macular edema following COVID-19 in a patient previously vaccinated with AstraZeneca and idiopathic myopathy
• Severe onset of inflammatory myositis in a child: think to paraneoplastic myositis
• Spontaneous Development of Immune-Mediated Necrotizing Myopathy (IMNM) After Chronic Use of Statins: A Case Report
• Sporadic Inclusion Body Myositis: MRI Findings and Correlation With Clinical and Functional Parameters
• The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis
• The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders
• The role and mechanism of myeloperoxidase in dermatomyositis
• Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies
• Value of the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the inflammatory myopathy population